News Release: Bringing About Change in Chronic Obstructive Pulmonary Disease (COPD) Care – IHE White Paper
The Institute of Health Economics releases the white paper, Bringing about change in COPD care.
The Institute of Health Economics has released the white paper, Bringing about change in COPD care. The purpose of the report is to suggest a platform for change to improve chronic obstructive pulmonary disease (COPD) care across Canadian jurisdictions, using the shared experiences of teams of health professionals that have found ways to provide innovative care.
The white paper concludes that the knowledge and technology needed to fill many of the gaps in care identified already exists in Canada. There is an important role that non-profit and networking organizations such as the national and provincial Lung Associations, the Canadian Thoracic Society, the Canadian Foundation for Health Improvement, and the Strategic Clinical Networks can play to help to bring about appropriate change to fill these gaps.
“This white paper is an important first step,” said Dr. Phillip Jacobs, Director of Research Collaborations at the Institute of Health Economics. “It calls for better data, a focus on key performance indicators which will better identify where the gaps are, and the initiatives that need to be taken to fill them.”
This report is a follow-up to the IHE report, Economic surveillance for chronic obstructive pulmonary disease (COPD) in Alberta, released earlier this year. A national expert advisory committee helped to inform and develop the report. Also included in the white paper were findings from the aforementioned economic surveillance report, a policy scan on gaps of care in Canada, and a national telephone survey of provincial Lung Associations.
“The white paper presents an exciting opportunity, as it provides a platform to improve patient care by identifying innovative existing solutions to known gaps in care,” said Peter Glazier, Vice President, Marketing, Communications and Development, The Lung Association (Ontario).
“We are passionate about improving health outcomes, and ensuring continuous innovation for the quality of care of COPD patients in Canada,” said Richard Mole, President and CEO, Boehringer Ingelheim (Canada) Ltd. “The recommendations outlined in the white paper will serve to help bridge the gap between patient need and the necessary steps that need to be taken in order to improve existing approaches to care.”
This report also comes following several consultations, including the COPD Economic Issues Policy Workshop that occurred last November. The workshop was videotaped and can be viewed on the IHE website.
Jasmine Brown, Institute of Health Economics
Office: (780) 448-4881 | Cell: (780) 966-4879
Email: [email protected]
Chronic Obstructive Pulmonary Disease (COPD) is a respiratory condition that is primarily caused by smoking, and is characterized by progressive, airflow obstruction that is not fully reversible (CTS Society). The condition cannot be cured, but can be managed through medical and non-medical interventions.